DE60131498T8 - VIRUSHÜLLENVEKTOR FüR DIE GENÜBERTRAGUNG - Google Patents

VIRUSHÜLLENVEKTOR FüR DIE GENÜBERTRAGUNG Download PDF

Info

Publication number
DE60131498T8
DE60131498T8 DE60131498T DE60131498T DE60131498T8 DE 60131498 T8 DE60131498 T8 DE 60131498T8 DE 60131498 T DE60131498 T DE 60131498T DE 60131498 T DE60131498 T DE 60131498T DE 60131498 T8 DE60131498 T8 DE 60131498T8
Authority
DE
Germany
Prior art keywords
covenant
virus
general transmission
transmission
general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE60131498T
Other languages
English (en)
Other versions
DE60131498D1 (de
DE60131498T2 (de
Inventor
Yasufumi Toyonaka-shi Kaneda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneda Yasufumi Toyonaka
Anges Inc
Original Assignee
Kaneda Yasufumi Toyonaka
Anges MG Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneda Yasufumi Toyonaka, Anges MG Inc filed Critical Kaneda Yasufumi Toyonaka
Publication of DE60131498D1 publication Critical patent/DE60131498D1/de
Publication of DE60131498T2 publication Critical patent/DE60131498T2/de
Application granted granted Critical
Publication of DE60131498T8 publication Critical patent/DE60131498T8/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation
    • C12N2710/16663—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18823—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18861—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18861—Methods of inactivation or attenuation
    • C12N2760/18863—Methods of inactivation or attenuation by chemical treatment
DE60131498T 2000-02-02 2001-02-02 VIRUSHÜLLENVEKTOR FüR DIE GENÜBERTRAGUNG Active DE60131498T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000025596 2000-02-02
JP2000025596 2000-02-02
PCT/JP2001/000782 WO2001057204A1 (fr) 2000-02-02 2001-02-02 Vecteur d'enveloppe virale pour transfert de gene

Publications (3)

Publication Number Publication Date
DE60131498D1 DE60131498D1 (de) 2008-01-03
DE60131498T2 DE60131498T2 (de) 2008-10-02
DE60131498T8 true DE60131498T8 (de) 2009-01-29

Family

ID=18551433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131498T Active DE60131498T8 (de) 2000-02-02 2001-02-02 VIRUSHÜLLENVEKTOR FüR DIE GENÜBERTRAGUNG

Country Status (10)

Country Link
US (3) US6913923B2 (de)
EP (1) EP1170363B1 (de)
KR (2) KR100776475B1 (de)
CN (3) CN101302536A (de)
AU (1) AU769385C (de)
CA (1) CA2369491C (de)
DE (1) DE60131498T8 (de)
HK (1) HK1047449A1 (de)
TW (1) TWI303663B (de)
WO (1) WO2001057204A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI303663B (en) * 2000-02-02 2008-12-01 Kaneda Yasufumi Inactivated virus envelope
EP1297852A4 (de) * 2000-06-27 2004-12-29 Dnavec Research Inc Viraler vektor zur einbringung von genen in nierenzellen(03.02.03)
TWI308492B (de) * 2001-02-20 2009-04-11 Anges Mg Inc
WO2003014338A1 (fr) * 2001-08-02 2003-02-20 Anges Mg, Inc. Procede de production d'enveloppes virales inactivees
KR20040040475A (ko) * 2001-09-28 2004-05-12 가부시키가이샤 디나벡크 겐큐쇼 에피토프 결합 β２ｍ을 코드하는 포유동물 세포감염성 바이러스 벡터 및 그의 이용
JPWO2003063911A1 (ja) 2002-02-01 2006-01-19 アンジェスＭｇ株式会社 デコイを含む薬学的組成物およびその使用方法
WO2003103721A1 (ja) * 2002-06-06 2003-12-18 アンジェス エムジー株式会社 脳血管障害遺伝子治療剤
CN1697879A (zh) * 2002-08-27 2005-11-16 安琪士多摩奇株式会社 利用病毒包膜导入生物分子的方法及其组合物和体系
US20060099218A1 (en) * 2002-10-01 2006-05-11 Dnavec Research Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity
AU2003280604A1 (en) * 2002-11-01 2004-05-25 Anges Mg, Inc. Medicinal preparation having chemotherapeutic encapsulated therein
WO2004046353A1 (ja) * 2002-11-21 2004-06-03 Genomidea Inc. 所望の機能的性質を有する核酸の単離方法およびそのためのキット
JP2004289816A (ja) * 2003-03-06 2004-10-14 Matsushita Electric Ind Co Ltd 遠隔制御装置、遠隔制御方法および被遠隔制御装置
JP4855250B2 (ja) 2004-03-31 2012-01-18 ジェノミディア株式会社 抗腫瘍作用を有する組成物
JP5170741B2 (ja) * 2004-04-27 2013-03-27 ウェルスタット バイオロジクス コーポレイション ウイルスおよびカンプトテシン類を使用する癌の処置
ES2357772T3 (es) * 2004-06-14 2011-04-29 Ishihara Sangyo Kaisha, Ltd. Composición liofilizada de envuelta viral inactivada con actividad de fusión de membrana.
MX2007015407A (es) * 2005-07-14 2008-02-19 Wellstat Biologics Corp Tratamiento del cancer utilizando virus, fluoropirimidinas y camptotecinas.
WO2007089780A2 (en) * 2006-01-30 2007-08-09 Licentia, Ltd. Bmx/etk tyrosine kinase gene therapy materials and methods
US20090053790A1 (en) * 2006-01-31 2009-02-26 Ishihara Sangyo Kaisha, Ltd. Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell
JP2008308440A (ja) * 2007-06-14 2008-12-25 Genomidea Inc 癌治療用薬剤送達ビヒクルおよびその製造方法ならびにそれを用いた製剤
EP2345415B1 (de) * 2008-09-16 2015-01-21 GenomIdea Inc. Therapeutisches/prophylaktisches mittel gegen prostatakrebs
EP2351574B1 (de) 2008-10-10 2016-08-24 Kringle Pharma, Inc. Promoter zur regeneration von sehnen-knochen-verbindungsgewebe oder bänder-knochen-verbindungsgewebe
EP4089169A1 (de) 2009-10-12 2022-11-16 Larry J. Smith Verfahren und zusammensetzungen zum modulieren der genexpression mit in-vivo oder in-vitro verabreichten arzneistoffen auf oligonukleotidbasis
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物
CA2797059A1 (en) * 2010-05-03 2011-11-10 Glaxosmithkline Biologicals S.A. Novel method
CN103941924B (zh) * 2014-04-25 2016-09-14 锐达互动科技股份有限公司 一种实现红外光编解码的互动投影方法
EP3536329B1 (de) 2016-11-01 2022-08-31 Osaka University Antikrebsmittel mit hvj-e und neutralisierenden antikörpers gegen pd-1
JP6799296B2 (ja) 2016-12-06 2020-12-16 国立大学法人大阪大学 新規プリオノイド病用治療薬
JPWO2022059703A1 (de) 2020-09-16 2022-03-24

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005476B1 (de) 1978-05-17 1981-12-30 Dr. Karl Thomae GmbH Verfahren zur Herstellung von Humaninterferon
CA1282721C (en) * 1984-06-04 1991-04-09 Bernard Roizman Herpes simplex virus as a vector
EP0555333B1 (de) * 1990-10-19 1995-12-27 University Of Florida Künstliche virushüllen
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5244635A (en) 1992-06-19 1993-09-14 Cirrus Diagnostics, Inc. Centrifuge vessel with coaxial waste chamber having cap to prevent waste fluid transfer from the chamber into the vessel
US5578475A (en) * 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
FR2713657B1 (fr) * 1993-12-13 1996-03-01 Transgene Sa Nouveaux vecteurs pour le traitement du sida.
US5843459A (en) 1996-01-19 1998-12-01 Human Gene Therapy Research Institute Differential inactivation of nucleic acids by chemical modification
JP3744583B2 (ja) * 1996-03-01 2006-02-15 株式会社ディナベック研究所 遺伝子導入用組成物及び該組成物を用いた遺伝子導入方法
US6451592B1 (en) * 1996-04-05 2002-09-17 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
US5683866A (en) 1996-05-09 1997-11-04 Sarkar; Debi P. Process for producing a targeted gene
US6183752B1 (en) * 1997-02-05 2001-02-06 Pasteur Merieux Serums Et Vaccins Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
US6051428A (en) * 1997-03-21 2000-04-18 Sloan-Kettering Institute For Cancer Research Rapid production of autologous tumor vaccines
US5849561A (en) 1997-05-22 1998-12-15 Cornell Research Foundation, Inc. Method for the production of non-group C adenoviral vectors
US6472375B1 (en) * 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6432925B1 (en) 1998-04-16 2002-08-13 John Wayne Cancer Institute RNA cancer vaccine and methods for its use
EP1137771A2 (de) * 1998-11-10 2001-10-04 The Board Of Regents, The University Of Texas System Verfahren zur vorbeugung von hypertrophie und versagen des herzens durch inhibierung des mefs-transkriptionsfaktors
TWI303663B (en) 2000-02-02 2008-12-01 Kaneda Yasufumi Inactivated virus envelope
US6509162B1 (en) * 2000-02-29 2003-01-21 Yale University Methods for selectively modulating survivin apoptosis pathways

Also Published As

Publication number Publication date
CN100542614C (zh) 2009-09-23
AU769385B2 (en) 2004-01-22
US20040219674A1 (en) 2004-11-04
WO2001057204A1 (fr) 2001-08-09
KR100847385B1 (ko) 2008-07-18
DE60131498D1 (de) 2008-01-03
KR20070059182A (ko) 2007-06-11
KR20020004987A (ko) 2002-01-16
US7279333B2 (en) 2007-10-09
DE60131498T2 (de) 2008-10-02
EP1170363A4 (de) 2002-06-12
EP1170363B1 (de) 2007-11-21
EP1170363A1 (de) 2002-01-09
CN1365388A (zh) 2002-08-21
CN1657103A (zh) 2005-08-24
CA2369491A1 (en) 2001-08-09
US7803621B2 (en) 2010-09-28
AU3057801A (en) 2001-08-14
AU769385C (en) 2004-07-29
KR100776475B1 (ko) 2007-11-16
CA2369491C (en) 2008-09-02
US20030013195A1 (en) 2003-01-16
CN100532559C (zh) 2009-08-26
US6913923B2 (en) 2005-07-05
TWI303663B (en) 2008-12-01
HK1047449A1 (zh) 2003-02-21
US20050239188A1 (en) 2005-10-27
CN101302536A (zh) 2008-11-12

Similar Documents

Publication Publication Date Title
DE60131498T8 (de) VIRUSHÜLLENVEKTOR FüR DIE GENÜBERTRAGUNG
DE60008582D1 (de) Meldungapplikation für sofortige nachrichtenübermittlung
DE50110649D1 (de) Zubereitung für restenoseprophylaxe
DE60134243D1 (de) Biegevorrichtung
DE60015362D1 (de) Zeitverzögerung für verbundene vorrichtungen
DE60234939D1 (de) Stent für die eustachische röhre
DE60140351D1 (de) Biegevorrichtung
DE60141316D1 (de) Indikator für die plasmasterilisation
NO20024738L (no) Felt-sveisbare koplinger
DE60134167D1 (de) Stanze
DE60229433D1 (de) Isches koppler
DE60140296D1 (de) Anbringung für näherungsradar
DE60211934D1 (de) Kupplung für rückhalterung
DE60217508D1 (de) Getriebe-antennenausrichtgerät
DE10294280D2 (de) Automatisierte Getriebesysteme
DE60102807T2 (de) Fahrzeuggetriebe
DE50101172D1 (de) Verbindungsanordnung für leitungen
DE60211052D1 (de) Abschulussvorrichtung für Ausgewuchtete Übertragung
DE10292235D2 (de) Getriebesystem
DE60216885D1 (de) Prozessor für die Befehlszeilenschnittstelle
DE60115364D1 (de) Herstellungsverfahren für stranggussknüppel
DE50107033D1 (de) Standardinterface für Fahrzeuge
DE60033477D1 (de) Arbitrierungsverfahren für Paketübertragung
FR2836018B3 (fr) Structure de bonnet pour soutien-gorge
IT1317820B1 (it) Reggiseno perfezionato.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition